1 Introduction to Research & Analysis Reports
    1.1 Cancer Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cancer Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cancer Drugs Overall Market Size
    2.1 Global Cancer Drugs Market Size: 2021 VS 2027
    2.2 Global Cancer Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Cancer Drugs Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Cancer Drugs Players in Global Market
    3.2 Top Global Cancer Drugs Companies Ranked by Revenue
    3.3 Global Cancer Drugs Revenue by Companies
    3.4 Global Cancer Drugs Sales by Companies
    3.5 Global Cancer Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Cancer Drugs Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Cancer Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Cancer Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Cancer Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Cancer Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Cancer Drugs Market Size Markets, 2021 & 2027
        4.1.2 Chemotherapy
        4.1.3 Targeted Therapy
        4.1.4 Immunotherapy
        4.1.5 Hormonal Therapy (Biologic Therapy)
        4.1.6 Others
    4.2 By Type - Global Cancer Drugs Revenue & Forecasts
        4.2.1 By Type - Global Cancer Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Cancer Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Cancer Drugs Revenue Market Share, 2016-2027
    4.3 By Type - Global Cancer Drugs Sales & Forecasts
        4.3.1 By Type - Global Cancer Drugs Sales, 2016-2021
        4.3.2 By Type - Global Cancer Drugs Sales, 2022-2027
        4.3.3 By Type - Global Cancer Drugs Sales Market Share, 2016-2027
    4.4 By Type - Global Cancer Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cancer Drugs Market Size, 2021 & 2027
        5.1.2 Blood Cancer
        5.1.3 Breast Cancer
        5.1.4 Gastrointestinal Cancer
        5.1.5 Prostate Cancer
        5.1.6 Respiratory/Lung Cancer
        5.1.7 Other Cancers
    5.2 By Application - Global Cancer Drugs Revenue & Forecasts
        5.2.1 By Application - Global Cancer Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Cancer Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Cancer Drugs Revenue Market Share, 2016-2027
    5.3 By Application - Global Cancer Drugs Sales & Forecasts
        5.3.1 By Application - Global Cancer Drugs Sales, 2016-2021
        5.3.2 By Application - Global Cancer Drugs Sales, 2022-2027
        5.3.3 By Application - Global Cancer Drugs Sales Market Share, 2016-2027
    5.4 By Application - Global Cancer Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Cancer Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Cancer Drugs Revenue & Forecasts
        6.2.1 By Region - Global Cancer Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Cancer Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Cancer Drugs Revenue Market Share, 2016-2027
    6.3 By Region - Global Cancer Drugs Sales & Forecasts
        6.3.1 By Region - Global Cancer Drugs Sales, 2016-2021
        6.3.2 By Region - Global Cancer Drugs Sales, 2022-2027
        6.3.3 By Region - Global Cancer Drugs Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Cancer Drugs Revenue, 2016-2027
        6.4.2 By Country - North America Cancer Drugs Sales, 2016-2027
        6.4.3 US Cancer Drugs Market Size, 2016-2027
        6.4.4 Canada Cancer Drugs Market Size, 2016-2027
        6.4.5 Mexico Cancer Drugs Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Cancer Drugs Revenue, 2016-2027
        6.5.2 By Country - Europe Cancer Drugs Sales, 2016-2027
        6.5.3 Germany Cancer Drugs Market Size, 2016-2027
        6.5.4 France Cancer Drugs Market Size, 2016-2027
        6.5.5 U.K. Cancer Drugs Market Size, 2016-2027
        6.5.6 Italy Cancer Drugs Market Size, 2016-2027
        6.5.7 Russia Cancer Drugs Market Size, 2016-2027
        6.5.8 Nordic Countries Cancer Drugs Market Size, 2016-2027
        6.5.9 Benelux Cancer Drugs Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Cancer Drugs Revenue, 2016-2027
        6.6.2 By Region - Asia Cancer Drugs Sales, 2016-2027
        6.6.3 China Cancer Drugs Market Size, 2016-2027
        6.6.4 Japan Cancer Drugs Market Size, 2016-2027
        6.6.5 South Korea Cancer Drugs Market Size, 2016-2027
        6.6.6 Southeast Asia Cancer Drugs Market Size, 2016-2027
        6.6.7 India Cancer Drugs Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Cancer Drugs Revenue, 2016-2027
        6.7.2 By Country - South America Cancer Drugs Sales, 2016-2027
        6.7.3 Brazil Cancer Drugs Market Size, 2016-2027
        6.7.4 Argentina Cancer Drugs Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Cancer Drugs Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Cancer Drugs Sales, 2016-2027
        6.8.3 Turkey Cancer Drugs Market Size, 2016-2027
        6.8.4 Israel Cancer Drugs Market Size, 2016-2027
        6.8.5 Saudi Arabia Cancer Drugs Market Size, 2016-2027
        6.8.6 UAE Cancer Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Roche
        7.1.1 Roche Corporate Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Cancer Drugs Major Product Offerings
        7.1.4 Roche Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.1.5 Roche Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Cancer Drugs Major Product Offerings
        7.2.4 Novartis Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.2.5 Novartis Key News
    7.3 Celgene
        7.3.1 Celgene Corporate Summary
        7.3.2 Celgene Business Overview
        7.3.3 Celgene Cancer Drugs Major Product Offerings
        7.3.4 Celgene Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.3.5 Celgene Key News
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Corporate Summary
        7.4.2 Bristol-Myers Squibb Business Overview
        7.4.3 Bristol-Myers Squibb Cancer Drugs Major Product Offerings
        7.4.4 Bristol-Myers Squibb Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.4.5 Bristol-Myers Squibb Key News
    7.5 Amgen
        7.5.1 Amgen Corporate Summary
        7.5.2 Amgen Business Overview
        7.5.3 Amgen Cancer Drugs Major Product Offerings
        7.5.4 Amgen Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.5.5 Amgen Key News
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Corporate Summary
        7.6.2 Johnson & Johnson Business Overview
        7.6.3 Johnson & Johnson Cancer Drugs Major Product Offerings
        7.6.4 Johnson & Johnson Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.6.5 Johnson & Johnson Key News
    7.7 Pfizer
        7.7.1 Pfizer Corporate Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Cancer Drugs Major Product Offerings
        7.4.4 Pfizer Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.7.5 Pfizer Key News
    7.8 Takeda
        7.8.1 Takeda Corporate Summary
        7.8.2 Takeda Business Overview
        7.8.3 Takeda Cancer Drugs Major Product Offerings
        7.8.4 Takeda Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.8.5 Takeda Key News
    7.9 Eli Lilly
        7.9.1 Eli Lilly Corporate Summary
        7.9.2 Eli Lilly Business Overview
        7.9.3 Eli Lilly Cancer Drugs Major Product Offerings
        7.9.4 Eli Lilly Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.9.5 Eli Lilly Key News
    7.10 AstraZeneca
        7.10.1 AstraZeneca Corporate Summary
        7.10.2 AstraZeneca Business Overview
        7.10.3 AstraZeneca Cancer Drugs Major Product Offerings
        7.10.4 AstraZeneca Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.10.5 AstraZeneca Key News
    7.11 Astellas
        7.11.1 Astellas Corporate Summary
        7.11.2 Astellas Cancer Drugs Business Overview
        7.11.3 Astellas Cancer Drugs Major Product Offerings
        7.11.4 Astellas Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.11.5 Astellas Key News
    7.12 Merck & Co.
        7.12.1 Merck & Co. Corporate Summary
        7.12.2 Merck & Co. Cancer Drugs Business Overview
        7.12.3 Merck & Co. Cancer Drugs Major Product Offerings
        7.12.4 Merck & Co. Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.12.5 Merck & Co. Key News
    7.13 Sanofi
        7.13.1 Sanofi Corporate Summary
        7.13.2 Sanofi Cancer Drugs Business Overview
        7.13.3 Sanofi Cancer Drugs Major Product Offerings
        7.13.4 Sanofi Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.13.5 Sanofi Key News
    7.14 Bayer
        7.14.1 Bayer Corporate Summary
        7.14.2 Bayer Business Overview
        7.14.3 Bayer Cancer Drugs Major Product Offerings
        7.14.4 Bayer Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.14.5 Bayer Key News
    7.15 Biogen Idec
        7.15.1 Biogen Idec Corporate Summary
        7.15.2 Biogen Idec Business Overview
        7.15.3 Biogen Idec Cancer Drugs Major Product Offerings
        7.15.4 Biogen Idec Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.15.5 Biogen Idec Key News
    7.16 Eisai
        7.16.1 Eisai Corporate Summary
        7.16.2 Eisai Business Overview
        7.16.3 Eisai Cancer Drugs Major Product Offerings
        7.16.4 Eisai Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.16.5 Eisai Key News
    7.17 Teva
        7.17.1 Teva Corporate Summary
        7.17.2 Teva Business Overview
        7.17.3 Teva Cancer Drugs Major Product Offerings
        7.17.4 Teva Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.17.5 Teva Key News
    7.18 Otsuka
        7.18.1 Otsuka Corporate Summary
        7.18.2 Otsuka Business Overview
        7.18.3 Otsuka Cancer Drugs Major Product Offerings
        7.18.4 Otsuka Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.18.5 Otsuka Key News
    7.19 Merck KGaA
        7.19.1 Merck KGaA Corporate Summary
        7.19.2 Merck KGaA Business Overview
        7.19.3 Merck KGaA Cancer Drugs Major Product Offerings
        7.19.4 Merck KGaA Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.19.5 Merck KGaA Key News
    7.20 Ipsen
        7.20.1 Ipsen Corporate Summary
        7.20.2 Ipsen Business Overview
        7.20.3 Ipsen Cancer Drugs Major Product Offerings
        7.20.4 Ipsen Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.20.5 Ipsen Key News
    7.21 AbbVie
        7.21.1 AbbVie Corporate Summary
        7.21.2 AbbVie Business Overview
        7.21.3 AbbVie Cancer Drugs Major Product Offerings
        7.21.4 AbbVie Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.21.5 AbbVie Key News
    7.22 Gilead Sciences
        7.22.1 Gilead Sciences Corporate Summary
        7.22.2 Gilead Sciences Business Overview
        7.22.3 Gilead Sciences Cancer Drugs Major Product Offerings
        7.22.4 Gilead Sciences Cancer Drugs Sales and Revenue in Global (2016-2021)
        7.22.5 Gilead Sciences Key News
8 Global Cancer Drugs Production Capacity, Analysis
    8.1 Global Cancer Drugs Production Capacity, 2016-2027
    8.2 Cancer Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Cancer Drugs Supply Chain Analysis
    10.1 Cancer Drugs Industry Value Chain
    10.2 Cancer Drugs Upstream Market
    10.3 Cancer Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer